An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)

Bio2RDF uri

An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)

http://bio2rdf.org/clinicaltrials:NCT00132730

Bio2RDF identifier

NCT00132730

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00132730

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00132730

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

604

http://www.w3.org/2001/XMLSchema#integer

brief summary [clinicaltrials_vocabulary:brief-summary]

This is a study to eval ...... ymptoms, and quality of life.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

An Investigational Drug Study ...... lmonary Disease) (MK-0873-005)

http://www.w3.org/2001/XMLSchema#string

clinical result [clinicaltrials_vocabulary:clinical-result]

clinical results for clinicaltrials:NCT00132730 [clinicaltrials_resource:e59d88324dd190f2bfd22b7adae81b82]

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) Pre-dose at Baseline and Treatment Weeks 8, 10 and 12 [clinicaltrials_resource:fcbc49242ab3a4c1bf0f127e7c50abba]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) Pre-dose at Baseline and Treatment Weeks 8, 10 and 12 [clinicaltrials_resource:1104ffa13d6d3695a79fa6c1152f2602]

Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) Pre-dose at Baseline and Treatment Weeks 8, 10 and 12 [clinicaltrials_resource:1fe7019fab6a597b57bcd73f9dbcab02]

Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) Pre-dose at Baseline and Treatment Weeks 8, 10 and 12 [clinicaltrials_resource:5a4e4d810c7511976dabe9fd825bb6c6]

Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) Pre-dose at Baseline and Treatment Weeks 8, 10 and 12 [clinicaltrials_resource:b28b11dfe867a3479ad7eb55f84a6b6c]

Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) Pre-dose at Baseline and Treatment Weeks 8, 10 and 12 [clinicaltrials_resource:b5b69f10a08c97b871781c40daa288b6]

Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) Pre-dose at Baseline and Treatment Weeks 8, 10 and 12 [clinicaltrials_resource:c0f986d1a36acd4e9bf030f390cc952a]

Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) Pre-dose at Baseline and Treatment Weeks 8, 10 and 12 [clinicaltrials_resource:f535cba068ac4a5708614a6438c5a81a]

completion date [clinicaltrials_vocabulary:completion-date]

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

Pulmonary Disease, Chronic Obstructive [clinicaltrials_resource:832780be347ce28ff9b5bf3fdda9b7f6]

Lung Diseases [clinicaltrials_resource:ca2bb7f91c2bc83d11609209905d6a3e]

condition browse [clinicaltrials_vocabulary:condition-browse]

Pulmonary Disease, Chronic Obstructive [clinicaltrials_resource:832780be347ce28ff9b5bf3fdda9b7f6]

Lung Diseases [clinicaltrials_resource:ca2bb7f91c2bc83d11609209905d6a3e]

Chronic Disease [clinicaltrials_resource:fdb3a0085fbaa761570f8e8017bdd81f]

condition mesh [clinicaltrials_vocabulary:condition-mesh]

Pulmonary Disease, Chronic Obstructive [clinicaltrials_resource:832780be347ce28ff9b5bf3fdda9b7f6]

Lung Diseases [clinicaltrials_resource:ca2bb7f91c2bc83d11609209905d6a3e]

Chronic Disease [clinicaltrials_resource:fdb3a0085fbaa761570f8e8017bdd81f]

country [clinicaltrials_vocabulary:country]

United States [clinicaltrials_resource:f253efe302d32ab264a76e0ce65be769]

detailed description [clinicaltrials_vocabulary:detailed-description]

Following a three-week ...... care or to usual care alone.

http://www.w3.org/2001/XMLSchema#string

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00132730 [clinicaltrials_resource:567c862a28a4ea91b1808c57ba9e5add]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2005-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

firstreceived results date [clinicaltrials_vocabulary:firstreceived-results-date]

2014-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

MK-0873 1.25 mg [clinicaltrials_resource:5d61765304cc3421af9d7e52b72b651e]

Usual Care [clinicaltrials_resource:6b93d0c4904e496be77f01b3dc610b32]

MK-0873 2.5 mg [clinicaltrials_resource:ad0393b09ac210981ca255879ab07199]

Placebo to MK-0873 [clinicaltrials_resource:c7209e9eda12f00a78830d6f616f452c]

MK-0873 0.75 mg [clinicaltrials_resource:f572dab0ed732c5d40c486f83f82951a]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

Yes

http://www.w3.org/2001/XMLSchema#string

is section 801 [clinicaltrials_vocabulary:is-section-801]

Yes

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2014-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Merck Sharp & Dohme Corp. [clinicaltrials_resource:bd932dcb36d27f98f1bb6129a9c0d723]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00132730

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

A Double-Blind, Randomized, Pl ...... MK-0873 in Patients With COPD

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

0873-005

http://www.w3.org/2001/XMLSchema#string

outcome [clinicaltrials_vocabulary:outcome]

Change From Baseline in Pre-dose (Trough) Forced Expiratory Volume in 1 Second (FEV1) [clinicaltrials_resource:NCT00132730/outcome/1]

overall official [clinicaltrials_vocabulary:overall-official]

Medical Monitor [clinicaltrials_resource:27195d211abb9273c80c26c3f8388190]

overall status [clinicaltrials_vocabulary:overall-status]

Terminated [clinicaltrials_resource:fba9c4daa2dd29d1077d32d965320ac1]

oversight [clinicaltrials_vocabulary:oversight]

Colombia: INVIMA Instituto Nacional de Vigilancia de Medicamentos y Alimentos [clinicaltrials_resource:b2b84c05c8491f85b8577912c5b51bae]

participant flow [clinicaltrials_vocabulary:participant-flow]

participant flow for clinicaltrials:NCT00132730 [clinicaltrials_resource:dc881a5dc4dd88ee012e31dd185e3050]

phase [clinicaltrials_vocabulary:phase]

Phase 2 [clinicaltrials_resource:56e0338b27a2d68f77402c88327b3f8d]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reported events [clinicaltrials_vocabulary:reported-events]

Reported events for NCT00132730 [clinicaltrials_resource:cf26905534eddf33377db42e92063b07]

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

secondary id [clinicaltrials_vocabulary:secondary-id]

2005_015

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

Merck Sharp & Dohme Corp. [clinicaltrials_resource:bd932dcb36d27f98f1bb6129a9c0d723]

start date [clinicaltrials_vocabulary:start-date]

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00132730 study design [clinicaltrials_resource:2f294869125a0303f17456961413915c]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00132730

verification date [clinicaltrials_vocabulary:verification-date]

2014-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00132730

http://www.w3.org/2001/XMLSchema#string